NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis: An inflammatory response beyond the realm of homeostasis

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2271-2277

  Rameshwar, P ^a   Narayanan, R ^a   Qian, J ^a   Denny, T N ^a   Colon, C ^a   Gascon, P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PHOSPHOTRANSFERASE; PROTEIN SUBUNIT; SALICYLATE SODIUM; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME INHIBITION; GENE INDUCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; KNOCKOUT GENE; LUNG FIBROSIS; MEDIATOR RELEASE; MONOCYTE; MOUSE; MYELOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

EID: 0034663758     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2271     Document Type: Article

References (54)

1. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
2. Current perspective in agnogenic myeloid metaplasia
3. Hematologic abnormalities in AIDS
4. Systemic lupus erythematosus and myelofibrosis
5. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen
6. Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis
7. Multilineage expression of haematopoietic precursors with an abnormal clone in idiopathic myelofibrosis
8. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome
9. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: Relation to collagen and reticulin fibrosis
10. A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: Evidence of an autoimmune pathogenesis
11. Idiopathic myelofibrosis: A possible role for immune complexes in the pathogenesis of bone marrow fibrosis
12. Implication of CD44 in adhesion-mediated overproduction of TGF-β and IL-1 in monocytes from patients with bone marrow fibrosis
13. TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders
14. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis
15. Systemic transforming growth factor-β in patients with bone marrow fibrosis: Pathological implications
16. Deposition of transforming growth factor-β in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-β by leukemic cells
17. Serum thrombopoietic level in various hematological diseases
18. Adhesion of monocytes from patients with bone marrow fibrosis is required for the production of fibrogenic cytokines: Potential role for IL-1 and TGF-β
19. Cell adhesion protein receptors as targets for transforming growth factor-β action
20. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders
21. Serum laminin P1 in idiopathic myelofibrosis and related diseases
22. Growth factors in the extracellular matrix
23. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis
24. The biology of macrophages
25. Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: An immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies
26. Ki-Sl and proliferating cell nuclear antigen expression of bone marrow macrophages
27. Regulation of adhesion and growth of fibrosarcoma cells by NF-κB Rel A involves transforming growth factor β
28. Evidence for differential functions of the p50 and p65 subunits of NF- κB with a cell adhesion model
29. NF-?B and rel proteins in innate immunity
30. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases
31. The NF-κB and IκB proteins: New discoveries and insights
32. Antisense oligonucleotides to the p65 subunit of NF-κB block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes
33. Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?
34. NF-κB activation: The IκB kinase revealed?
35. Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein-and NF-κB-responsive genes
36. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
37. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation
38. In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice
39. Release of interleukin-1 and interleukin-6 from human monocytes by antithymocyte globulin: Requirement for de novo synthesis
40. Selection of optimal κB/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation
41. Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynuceotides
42. Interleukin-1 signaling occurs exclusively via type I receptor
43. Over-expression of IκBα without inhibition of NF-κB activity and mutations in the IκBα gene in Reed-Sternberg cells
44. Promoter sequences of the human transforming growth factor-β1 autoinduction
45. Regulation of NF-κB activation in T helper 1 and T helper 2 cells
46. TGF-β-induced matrix proteins inhibit p2/44 MAPK and JNK activation and suppress TNF-mediated IκBα degradation and NF-κB nuclear translocation in L929 fibroblasts
47. NF-κB controls expression of inhibitor IκBa: Evidence for an inducible autoregulatory pathway
48. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells
49. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease
50. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic autocrine stimulation by Mpl-L
51. Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts
52. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia
53. Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis
54. Peripheral blood and bone marrow findings in patients with acquired immunodeficiency syndrome